Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Phase of Trial: Phase III
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Idalopirdine (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Registrational; Therapeutic Use
- Acronyms STARSHINE
- Sponsors Lundbeck A/S
- 20 Jul 2017 Results (n=2525) from STAR Phase III Program (NCT01955161, NCT02006641, NCT02006654), presented at the Alzheimer's Association International Conference 2017.
- 23 Sep 2016 Status changed from active, no longer recruiting to completed.
- 22 Sep 2016 Results published in a Lundbeck media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History